pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-514a-1 |
Genomic Coordinates | chrX: 147279247 - 147279344 |
Description | Homo sapiens miR-514a-1 stem-loop |
Comment | The mature sequence shown here represents the most commonly cloned form from large-scale cloning studies . |
RNA Secondary Structure | ![]() |
Associated Diseases | ![]() |
pre-miRNA | hsa-mir-514a-2 |
Genomic Coordinates | chrX: 147281943 - 147282030 |
Description | Homo sapiens miR-514a-2 stem-loop |
Comment | The mature sequence shown here represents the most commonly cloned form from large-scale cloning studies . |
RNA Secondary Structure | ![]() |
Associated Diseases | ![]() |
pre-miRNA | hsa-mir-514a-3 |
Genomic Coordinates | chrX: 147284641 - 147284728 |
Description | Homo sapiens miR-514a-3 stem-loop |
Comment | The mature sequence shown here represents the most commonly cloned form from large-scale cloning studies . |
RNA Secondary Structure | ![]() |
Associated Diseases | ![]() |
Mature miRNA Information | ||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-514a-5p | |||||||||||||||||||||||||||||||||||||||
Sequence | 22| UACUCUGGAGAGUGACAAUCAUG |44 | |||||||||||||||||||||||||||||||||||||||
Evidence | Not_experimental | |||||||||||||||||||||||||||||||||||||||
Experiments | ||||||||||||||||||||||||||||||||||||||||
SNPs in miRNA |
|
|||||||||||||||||||||||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | UBE4A | ||||||||||||||||||||
Synonyms | E4, UBOX2, UFD2 | ||||||||||||||||||||
Description | ubiquitination factor E4A | ||||||||||||||||||||
Transcript | NM_004788 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on UBE4A | |||||||||||||||||||||
3'UTR of UBE4A (miRNA target sites are highlighted) |
>UBE4A|NM_004788|3'UTR
1 ATACTGTGAACTAACCAAACCAAAACCAACCCCAGAGTGCAGATAAACAATTGTTTGTGGTTTCTCTCTTTCTGGTTCTG
81 TTCCTTTTCTTTCTTCTTTTCTTTTTCTTTTTTTTTTTTTTTTTTACTAAATTAGAGAACTGCTCTTGCTGAAATTATGA
161 TAGTTAAGATTCCTAAGAACTTGACAATGCTCCCCTGGCTTGCAGGAAATTATACTTATTATAGCATCACCAAGTTTAGA
241 AATCATCACTAATTTTCACCCTCTGTTGTCTCTTCATATTCTTCTTCCTTTTCCTAAATGAAATTATATTATTTCAACTA
321 CTAAAACTTCCCGCCACCCTGCTATTTCTCTTCCAATTACTGTTCAAACATTTTTGGTGAGTGCTGCTTTTATAAATATG
401 TGATGTCACATATTTCAGTGACAGCTGATGTTATCAGAAAAATCCTGTTATCCTGTGTATTTACTAGTCCTCATGATCTA
481 GACTTAACCCCTTTTCTGTGTTACAGAGTAACTTCACATAAAAGCAGATACCTTTAAGTTTGTGTAGACTTCTGAATAAG
561 ATGATAGACGAGAATTTTTTTTAAAAAAGGAATTTAAAGGAATCTTGTGCAACTTCTGTTGATAGCTCTTAATTTTGTTA
641 TACAGTCTTTTTAATGAGGATTGGTAGGGCAATCCTACCAATTGATGGGGGTGAGGAGACTGTTGGGCCCTTATTCTCTT
721 ATGAAAATCTGTTTCTACAAGGACTAGGCCTAAGTAGATTTAGGCAACGGGTATCATATCCATGAAAAATGTCATTTTAA
801 GACACTAATATCAACAGTATATCTCAGTGTGTGAGATATATAAATACACATACACCCCATGTGCTTTTTTGTTGGTTTAG
881 TGTAAACTGAGTACCACTTTATATTTTCTCTTCCATAGTGAGATGTATGCAGTATGTGGCCATGTTTACTAACATACTCA
961 TTCTTCACAAAATTCTGAGATTATAAAATGTATATAGTTAATATTTGTTTGAGCTTGTGACCTGACTTCTAAGAGCTACT
1041 TCTAACACAGCCTTAGGTCTTCAATTAACAAAGTAGGAAGTTGAGCACAACCTTGTCCACAGCCATTTTAAATATCCACT
1121 TAGCCCTGTGTAGTTGGTAGGTGGACACCACTTTCATAAGTGAACTTGAGCTCACTACTCAATTGTGCAGCTTAATATGC
1201 TGACTAGGGACATTCCCCTATGGATTATCTTTATATCACTGTCTTTCTAAGCCCAGAGATGTCATAAGTGACAAGAAAAG
1281 TGATAGGATCAAGAAATGGGTGTCACTGCTTCATTTGGAACATGTTATTAACTATGGTCTCTTTCAAATAAATAGTAGTT
1361 TTATATTTCAACACAAGTTGCTATAAGCAGTCCTTGATGGGTTTTTGATTGCATCAGCTGGAAAGCCTCAAATCTAAGAG
1441 GGCTTCCCATCCTAGATATAAAATAGGTGTTGCCTATTGCTGTGCTTATAAAATGAAAAAGGAAATTGAGGACACTTTTG
1521 CAAATGCCAGAATGTAAGATTCATTCAGTGTGCTCCCTGGGCCTTTATGGCATGGGTTGACAGGATTTGTTTATTTTCTA
1601 AAATTAGCTTCATTCAATATTTATCATCCTCCTTTCCCTCTCTGAGAATGAACTATGTATAAAATAAGCTTCTGCCTATT
1681 TGCATTTATCTTCCAAACCCAATCTAGTAGGATGTTCTCATTTTAAAAACGAGGGGAAAAGACCAGAGTTTTTCAGGAGA
1761 AAACTGGAGGAAAATGGGCACAAAAACTCAGAAGGCAGCTATTCCCAGCAGCTTCCTAGTTAACAACCCCCATGCTGCCT
1841 CCAGTCTTTGTCTGTATTCTTCTGTATTTAACCTTCAGATTGTAAGCCTTTTCTGGCAAGCTTTTCTTCTTTTTTTAAAC
1921 TCTTTTCCTGAAACTTTTTATGAATGGCTATGGCACCATTAATGCTGCTGAATATCTTTAAACTCTGCACAAGCAAGTGT
2001 GTAGCTTAAGGCCACTACTGGTAAGGAAACCAAGTGTCCTCTGTGCCTTTTTTCTTTCTGTGAAGTAATTTAAGAATATC
2081 CAAAAAAATTAGACTTTAAAAAGTTATCTTGGTACAACACCGTGTGTATATACACTTGGAAGCTTAAAAAGGTGTTTTGT
2161 CTGGAACTTAGAAGCAGCTCTAAATCTAGTAGAGCAGACTTTCTAACATACCTAGTTTTGTGTATTGGCTTTGCTGGAGT
2241 ATGATAGCAAAATGAAGACTCTTTTACTCAGCTCTGGTATTGCTCATAACTTACCAAGAGGCTAATACTAAACTTGGAAA
2321 ATTGTTTAAGTATGTTTTATCAAGCAGTCTGGGTTTTGTTTTTTAATATACTTTTTAATGGATATGTGAAAACTGAAGGA
2401 AATGTTAAAGGTTTTTTAATGGTGCAAGTGAAGGTGCCAGTTGCTATTTGATATCACACTCTACAAAAGCTTCATTACTT
2481 TATTTGATGGTGGTTGCTAAGCAGCCATTGCACAGAGCATAAGTCTACTGGGTGCCTTTACATGCCAGAGGCTGATGCTG
2561 CACTGTTGATGTCATGTGAGGAAATAATGCACATGCTCTAACTGCTCAACAGGAAATGAACCTAGAAACAGAAAATGAAA
2641 AGGTTGATTGAAATAAAACTTGATCAACGCGACTGTATTTTGAAACATTCCAGGAAGGTTACTTCTTGTCAAACTTGCCT
2721 GGCAGTGTTTGTTCAAAACTTGTATTTAATAAATGAACATCTGACTTACAAAAAAAAAAAAAAAAAA
Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | TZM-bl | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM1462574. RNA binding protein: AGO2. Condition:TZM-bl ami BaL
... - Whisnant AW; Bogerd HP; Flores O; Ho P; et al., 2013, mBio. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Whisnant AW; Bogerd HP; Flores O; Ho P; et al. - mBio, 2013
UNLABELLED: The question of how HIV-1 interfaces with cellular microRNA (miRNA) biogenesis and effector mechanisms has been highly controversial. Here, we first used deep sequencing of small RNAs present in two different infected cell lines (TZM-bl and C8166) and two types of primary human cells (CD4(+) peripheral blood mononuclear cells [PBMCs] and macrophages) to unequivocally demonstrate that HIV-1 does not encode any viral miRNAs. Perhaps surprisingly, we also observed that infection of T cells by HIV-1 has only a modest effect on the expression of cellular miRNAs at early times after infection. Comprehensive analysis of miRNA binding to the HIV-1 genome using the photoactivatable ribonucleoside-induced cross-linking and immunoprecipitation (PAR-CLIP) technique revealed several binding sites for cellular miRNAs, a subset of which were shown to be capable of mediating miRNA-mediated repression of gene expression. However, the main finding from this analysis is that HIV-1 transcripts are largely refractory to miRNA binding, most probably due to extensive viral RNA secondary structure. Together, these data demonstrate that HIV-1 neither encodes viral miRNAs nor strongly influences cellular miRNA expression, at least early after infection, and imply that HIV-1 transcripts have evolved to avoid inhibition by preexisting cellular miRNAs by adopting extensive RNA secondary structures that occlude most potential miRNA binding sites. IMPORTANCE: MicroRNAs (miRNAs) are a ubiquitous class of small regulatory RNAs that serve as posttranscriptional regulators of gene expression. Previous work has suggested that HIV-1 might subvert the function of the cellular miRNA machinery by expressing viral miRNAs or by dramatically altering the level of cellular miRNA expression. Using very sensitive approaches, we now demonstrate that neither of these ideas is in fact correct. Moreover, HIV-1 transcripts appear to largely avoid regulation by cellular miRNAs by adopting an extensive RNA secondary structure that occludes the ability of cellular miRNAs to interact with viral mRNAs. Together, these data suggest that HIV-1, rather than seeking to control miRNA function in infected cells, has instead evolved a mechanism to become largely invisible to cellular miRNA effector mechanisms.
LinkOut: [PMID: 23592263]
|
Experimental Support 2 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | HCT116 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in ERX177599. RNA binding protein: AGO2. Condition:p53_D_AGO_CLIP_2_1
PAR-CLIP data was present in ERX177611. RNA binding protein: AGO2. Condition:p53_D_AGO_CLIP_3_1
... - Krell J; Stebbing J; Carissimi C; Dabrowska et al., 2016, Genome research. |
Article |
- Krell J; Stebbing J; Carissimi C; Dabrowska et al. - Genome research, 2016
DNA damage activates TP53-regulated surveillance mechanisms that are crucial in suppressing tumorigenesis. TP53 orchestrates these responses directly by transcriptionally modulating genes, including microRNAs (miRNAs), and by regulating miRNA biogenesis through interacting with the DROSHA complex. However, whether the association between miRNAs and AGO2 is regulated following DNA damage is not yet known. Here, we show that, following DNA damage, TP53 interacts with AGO2 to induce or reduce AGO2's association of a subset of miRNAs, including multiple let-7 family members. Furthermore, we show that specific mutations in TP53 decrease rather than increase the association of let-7 family miRNAs, reducing their activity without preventing TP53 from interacting with AGO2. This is consistent with the oncogenic properties of these mutants. Using AGO2 RIP-seq and PAR-CLIP-seq, we show that the DNA damage-induced increase in binding of let-7 family members to the RISC complex is functional. We unambiguously determine the global miRNA-mRNA interaction networks involved in the DNA damage response, validating them through the identification of miRNA-target chimeras formed by endogenous ligation reactions. We find that the target complementary region of the let-7 seed tends to have highly fixed positions and more variable ones. Additionally, we observe that miRNAs, whose cellular abundance or differential association with AGO2 is regulated by TP53, are involved in an intricate network of regulatory feedback and feedforward circuits. TP53-mediated regulation of AGO2-miRNA interaction represents a new mechanism of miRNA regulation in carcinogenesis.
LinkOut: [PMID: 26701625]
|
CLIP-seq Support 1 for dataset GSM1462574 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | TZM-bl / TZM-bl ami BaL |
Location of target site | ENST00000252108.3 | 3UTR | AUACUGUGAACUAACCAAACCAAAACCAACCCCAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23592263 / GSE59944 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
54 hsa-miR-514a-5p Target Genes:
Functional analysis:
ID![]() |
Target | Description | Validation methods |
![]() |
![]() |
|||||||
Strong evidence | Less strong evidence | |||||||||||
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
|||||
MIRT109577 | KLHL15 | kelch like family member 15 | ![]() |
![]() |
2 | 2 | ||||||
MIRT441831 | ALG14 | ALG14, UDP-N-acetylglucosaminyltransferase subunit | ![]() |
![]() |
2 | 2 | ||||||
MIRT442362 | UHRF1BP1L | UHRF1 binding protein 1 like | ![]() |
![]() |
2 | 2 | ||||||
MIRT446171 | C8A | complement C8 alpha chain | ![]() |
![]() |
2 | 2 | ||||||
MIRT463212 | ZNF148 | zinc finger protein 148 | ![]() |
![]() |
2 | 2 | ||||||
MIRT464637 | UBE4A | ubiquitination factor E4A | ![]() |
![]() |
2 | 2 | ||||||
MIRT490619 | SLC47A1 | solute carrier family 47 member 1 | ![]() |
![]() |
2 | 4 | ||||||
MIRT491282 | DHX40 | DEAH-box helicase 40 | ![]() |
![]() |
2 | 2 | ||||||
MIRT502074 | KRAS | KRAS proto-oncogene, GTPase | ![]() |
![]() |
2 | 2 | ||||||
MIRT504057 | TOMM5 | translocase of outer mitochondrial membrane 5 | ![]() |
![]() |
2 | 2 | ||||||
MIRT529231 | CYP20A1 | cytochrome P450 family 20 subfamily A member 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT530918 | SAP30L | SAP30 like | ![]() |
![]() |
2 | 2 | ||||||
MIRT539010 | AVL9 | AVL9 cell migration associated | ![]() |
![]() |
2 | 2 | ||||||
MIRT544654 | PHF8 | PHD finger protein 8 | ![]() |
![]() |
2 | 4 | ||||||
MIRT548487 | EEF2 | eukaryotic translation elongation factor 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT566598 | NUFIP2 | NUFIP2, FMR1 interacting protein 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT566738 | MSANTD4 | Myb/SANT DNA binding domain containing 4 with coiled-coils | ![]() |
![]() |
2 | 2 | ||||||
MIRT575151 | Reep5 | receptor accessory protein 5 | ![]() |
![]() |
2 | 3 | ||||||
MIRT607506 | REEP5 | receptor accessory protein 5 | ![]() |
![]() |
2 | 3 | ||||||
MIRT609630 | TRPC4AP | transient receptor potential cation channel subfamily C member 4 associated protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT625605 | KLHL23 | kelch like family member 23 | ![]() |
![]() |
2 | 2 | ||||||
MIRT626188 | SRFBP1 | serum response factor binding protein 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT626731 | TRIM65 | tripartite motif containing 65 | ![]() |
![]() |
2 | 2 | ||||||
MIRT630313 | PDP2 | pyruvate dehyrogenase phosphatase catalytic subunit 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT631673 | VMAC | vimentin type intermediate filament associated coiled-coil protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT632217 | ZFP62 | ZFP62 zinc finger protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT633969 | GRWD1 | glutamate rich WD repeat containing 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT636971 | YY2 | YY2 transcription factor | ![]() |
![]() |
2 | 2 | ||||||
MIRT637341 | DARS2 | aspartyl-tRNA synthetase 2, mitochondrial | ![]() |
![]() |
2 | 4 | ||||||
MIRT637393 | R3HDM2 | R3H domain containing 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT650380 | MOCS3 | molybdenum cofactor synthesis 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT662553 | MTAP | methylthioadenosine phosphorylase | ![]() |
![]() |
2 | 2 | ||||||
MIRT664112 | FUT1 | fucosyltransferase 1 (H blood group) | ![]() |
![]() |
2 | 2 | ||||||
MIRT664478 | ZYG11B | zyg-11 family member B, cell cycle regulator | ![]() |
![]() |
2 | 2 | ||||||
MIRT669679 | ACAP2 | ArfGAP with coiled-coil, ankyrin repeat and PH domains 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT669913 | KIAA0754 | KIAA0754 | ![]() |
![]() |
2 | 4 | ||||||
MIRT670374 | ULBP3 | UL16 binding protein 3 | ![]() |
![]() |
2 | 4 | ||||||
MIRT670648 | BVES | blood vessel epicardial substance | ![]() |
![]() |
2 | 2 | ||||||
MIRT670676 | KIAA1551 | KIAA1551 | ![]() |
![]() |
2 | 2 | ||||||
MIRT670758 | HOOK3 | hook microtubule tethering protein 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT671325 | ACTR1A | ARP1 actin related protein 1 homolog A | ![]() |
![]() |
2 | 2 | ||||||
MIRT672023 | PXMP4 | peroxisomal membrane protein 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT675326 | TBL2 | transducin beta like 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT675912 | C17orf85 | nuclear cap binding subunit 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT684884 | P4HB | prolyl 4-hydroxylase subunit beta | ![]() |
![]() |
2 | 2 | ||||||
MIRT685291 | KIAA1143 | KIAA1143 | ![]() |
![]() |
2 | 2 | ||||||
MIRT691639 | CDK1 | cyclin dependent kinase 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT703936 | EPG5 | ectopic P-granules autophagy protein 5 homolog | ![]() |
![]() |
2 | 2 | ||||||
MIRT713837 | NUP98 | nucleoporin 98 | ![]() |
![]() |
2 | 2 | ||||||
MIRT714334 | DIP2A | disco interacting protein 2 homolog A | ![]() |
![]() |
2 | 2 | ||||||
MIRT717948 | TUBD1 | tubulin delta 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT718374 | RBM8A | RNA binding motif protein 8A | ![]() |
![]() |
2 | 2 | ||||||
MIRT719945 | SNX8 | sorting nexin 8 | ![]() |
![]() |
2 | 2 | ||||||
MIRT725629 | CAMKV | CaM kinase like vesicle associated | ![]() |
![]() |
2 | 2 |
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|